Opinion|Videos|February 3, 2025
Setting Goals for Pediatric Atopic Dermatitis Treatment
Panelists discuss the goals of treating atopic dermatitis, focusing on symptom control and quality of life, with treatment differing for children and adults, and emphasize using assessment tools such as Eczema Area and Severity Index (EASI)-75/90, Investigator Global Assessment (IGA), and itch scores alongside patient-reported outcomes to guide decisions while also considering disease severity and the impact of atopic comorbidities in treatment approaches.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the goals of treatment for a patient with atopic dermatitis?
- How do treatment goals differ for atopic dermatitis in the pediatric population compared with adults?
- How do you leverage standard assessment tools such as EASI-75/90, IGA, and itch scores vs patient- and caregiver-reported outcomes?
- When considering disease severity and a treatment approach, how do you determine systemic eligibility in a pediatric patient?
- Does the presentation of atopic comorbidities dictate a treatment approach?
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Maternal influenza, TDaP vaccination linked to fewer infant hospital and emergency visits
2
Phase 3 Beeline trial begins evaluating radiprodil in GRIN-related neurodevelopmental disorder
3
FDA approves Zycubo for treatment of Menkes disease in children
4
Adverse prenatal exposures linked to adolescent mental health risk
5